Abstract
Inflammation and increased capillary permeability is a significant aspect of the pathogenesis of many diseases including atherosclerosis. L-type calcium channel blockers (CCB) are commonly used as cardiovascular drugs. Amlodipine, lacidipine, and nicardipine were evaluated for anti-inflammatory activity on the paw oedema produced by carrageenan. The effect of these drugs was compared with the activity of indomethacin. Their effects on vascular permeability were also tested by hyaluronidase-induced capillary permeability. In our animal experiments, amlodipine decreased the carrageenan-induced paw oedema at doses of 1, 3, and 6 mg kg−1 by 27.3%, 43.7%, and 67.3% four hour after carrageenan administration; the same doses of lacidipine and nicardipine decreased paw oedema by 37.1%, 55.6%, 76.4%, 11.2%, 31.0%, 91%; and indomethacin decreased oedema by 38.2% at a dose of 6 mg kg−1. Lacidipine significantly inhibited the hyaluronidase-induced increase in capillary permeability at doses of 1, 3, and 6 mg kg−1 compared with the control group. However, amlodipine and nicardipine significantly inhibited the hyaluronidase-induced increase in capillary permeability at 3 and 6 mg kg−1 doses. A 6 mg kg−1 dose of indomethacin significantly decreased the capillary permeability which was increased by hyaluronidase. These results suggest that CCBs can be efficient anti-inflammatories, and can also significantly decrease capillary permeability.
Similar content being viewed by others
References
Abernethy, D. R. and Schwartz, J. B., Calcium-antagonist drugs. N Engl J Med., 341, 1447–1457 (1999).
Aditya, G. N., Chattopadhyay, R. N., Mandal, S., Roy, R. K., Lahiri, H. L., Maitra, S. K. et al., Preliminary study on antiinflammatory effect of calcium channel blockers in albino rats. Indian Journal of Pharmacology., 29, 132–134 (1997).
Al-Naemi, H. and Baldwin, A. L., Nitric oxide protects venules against histamine-induced leaks. Microcirculation, 7, 215–223 (2000).
Bilici, D., Akpinar, E., Gursan, N., Dengiz, G. O., Bilici, S., and Atlas, S., Protective effect of T-type calcium channel blocker in histamine-induced paw inflammation in rat. Pharmacol Res., 44, 527–531 (2001).
Carnevale, K. A. and Cathcart, M., Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1. J Immunol., 167, 3414–3421 (2001).
Chand, N., Pillar, J., Diamantis, W., and Sofia, R. D., In vitro inhibition of allergic histamine release by calcium antagonists. Eur J Pharmacol., 107, 353–358 (1985).
Chen, L., Haught, W. H., Yang, B., Saldeen, T. G., Parathasarathy, S., and Mehta, J. L., Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol., 30, 569–575 (1997).
Cominacini, L., Pasini, A. F., Pastorino, A. M., Garbin, U., Davoli, A., Rigoni, A. et al., Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells. J Hypertens., 17, 1837–1841 (1999).
De Souza, A. P., Tanowitz, H. B., Chandra, M., Shtutin, V., Weiss, L. M., Morris, S. A. et al., Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res., 92, 496–501 (2004).
El-Bizri, N., Bkaily, G., Wang, S., Jacques, D., Regoli, D., D’Orleans-Juste, P. et al., Bradykinin induced a positive chronotropic effect via stimulation of T-and L-type calcium currents in heart cells. Can J Physiol Pharmacol., 81, 247–258 (2003).
Elferink, J. G., Boonen, G. J., and De Koster, B. M., The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils. Biochem Biophys Res Commun., 31, 864–869 (1992).
Elferink, J. G., Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes. Arzneimittelforschung, 32, 1417–1420 (1982).
Fuster, V., Badimon, L., Badimon, J. J., and Chesebro, J. H., The pathogenesis of coronary artery disease and the acute coronary syndromes (2). New Engl. J. Med., 326, 310–318 (1992).
Grossman, E. and Meserli, F. H., Calcium antagonists. Prog Cardiovasc Dis., 47, 34–57 (2004).
Gurdal, H., Sara, Y., and Tulunay, F. C., Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats. Pharmacology., 44, 290–296 (1992).
Henry, P. D., Atherosclerosis, calcium, and calcium antagonists. Circulation, 72, 456–459 (1985).
Henry, P. D. and Bentley, K., Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest., 68, 1366–1369 (1989).
Houck, J. C. and Chang, C. M., Permeability factor contaminating hyaluronidase preparations. Inflammation, 3, 447–451 (1979).
Huang, Q. and Yuan, Y., Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol., 273, 42–2451 (1997).
Janssen, B. J., Kam, K. L., and Smits, J. F., Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol., 364, 14–421 (2001).
Kouoh, F., Gressier, B., Dine, T., Luyckx, M., Brunet, C., and Ballester, L., Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential antiatherosclerotic property of calcium antagonists. Cardiovasc Drugs Ther., 16, 515–520 (2006).
Kramsch, D. M., Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent. Int J Cardiol., 62, 119–124 (1997).
Leslie, C. C., Properties and regulation of cytosolic phospholipase A2. J Biol Chem., 272, 16709–16712 (1997).
Liao, F., Andalibi, A., Qiao, J. H., Allayee, H., Fogelman, A. M., and Lusis, A. J., Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest., 94, 877–884 (1994).
Libby, P., Molecular bases of the acute coronary syndromes. Circulation, 91, 2844–2850 (1995).
Martinez, L. L., Aparecida, De Oliveira, M., and Fortes, Z. B., Influence of verapamil and diclofenac on leukocyte migration in rats. Hypertension., 34, 997–1001 (1999).
Marzocco, S., Di Paola, R., Serraino, I., Sorrentino, R., Meli, R., and Mattaceraso, G., Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol., 26, 341–350 (2004).
Maslinska, D. and Gajewski, M., Some aspects of the inflammatory process. Folia Neuropathol., 36, 199–204 (1998).
Mason, R. P., Cytoprotective properties of a long-acting calcium channel blocker: new mechanism of action. Am J Hypertension., 11, 245A (1998).
Mason, R. P., Walter, M. F., Trumbore, M. W., Olmstead, E. G. Jr., and Mason, P. E., Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol., 31, 275–281 (1999).
Mohler, E. R 3rd, Sorensen, L. C., Ghali, J. K., Schocken, D. D., Willis, P. W., and Bowers, J. A., Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial Prospective Randomized Amlodipine Survival Evaluation. J Am Coll Cardiol., 30, 35–41 (1997).
Neto, A. G., Costa, J. M., Belati, C. C., Vinholis, A. H., Possebom, L. S., Da Silva, and Filho, A. A., Analgesic and anti-inflammatory activity of a crude root extract of Pfaffia glomerata (Spreng) Pedersen. J Ethnopharmacol., 96, 87–91 (2005).
Oates, J. A. and Brown, N. J., Drugs affecting renal and cardiovascular function: Antihypertensive Agents and the Drug Therapy of Hypertension. In: Brunton L, editor. Godman and Gilman’s the pharmacological basis of therapeutics. New-York: Mc Graw-Hill; pp. 671–717 (2006)
Pitt, B., Byington, R. P., Furberg, C. D., Hunninghake, D. B., Mancini, G. B., Miller, M. E. et al., Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation., 102, 1503–151 (2000).
Procida, C., Mantovani, V., and Bianchini, P., Anti-hyaluronidase activity of some pyrazole derivatives. Boll Soc Ital Biol Sper., 47, 159–163 (1971).
Ramprasath, V. R., Shanthi, P., and Sachdanandam, P., Antiinflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions. Biol Pharm Bull., 27, 2028–2031 (2004).
Ross, R., Atherosclerosis an inflammatory disease. N Engl J Med, 340, 115–126 (1999).
Salomone, S., Silva, C. L., Morel, N., and Godfraind, T., Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery. Naunyn Schmiedebergs Arch Pharmacol., 354, 505–512 (1996).
Siflinger-Birnboim, A., Lum, H., Del Vecchio, P. J., Malik, A. B., Involvement of Ca2+ in the H2O2-induced increase in endothelial permeability. Am J Physiol., 270, 973–978 (1996).
Siflinger-Birnboim, A. and Malik, A. B., Regulation of endothelial permeability by second messengers. New Horiz., 4, 87–98 (1996).
Sirmagul, B., Kilic, F. S., Batu, O., and Erol, K., The effects of verapamil on stress-and histamine-induced gastric lesions in rats. Methods Find Exp Clin Pharmacol., 26, 763 (2004).
Suleyman, H., Gul, H. I., and Asoglu, M., Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride. Pharmacol Res., 47, 471–475 (1998).
Suleyman, H., Demirezer, L.O., Kuruuzum., Banoglu, Z. N., Gocer, F., and Ozbakir, G., Antiinflammatory effect of the aqueous extract from Rumex patientia L. roots. J Ethnopharmacol., 65, 141–148 (1999).
Suleyman, H., Odabasoglu, F., Aslan, A., Cakir, A., Karagoz, Y., and Gocer, F., Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria pulmonaria (L.) Hoffm. Phytomedicine., 10, 552–557 (2003).
Suleyman, H., Halici, Z., Hacmuftuoglu, A., and Gocer, F., Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers. Pharmacol Rep., 58, 692–699 (2006).
Suleyman, H., Gul, H. I., Gul, M., Alkan, M., and Gocer, F., Antiinflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat. Biol Pharm Bull., 30, 63–67 (2007).
Tulenko, T. N., Laury-Kleintop, L., Walter, M. F., and Mason, R. P., Cholesterol, calcium and atherosclerosis: Is there a role forcalcium channel blockers in atheroprotection? Int J Cardiol., 62, 55–66 (1997).
Tulenko, T. N., Step, D. W., Chen, M. et al., Actions of the charged dihydropyridine amlodipine in a cell culture model of dietary atherosclerosis. J Cardiovasc Pharmacol, 126, 11–17 (1995).
Winter, C. A., Risley, E. A., and Nuss, G. W., Carrageenininduced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med., 111, 544–547 (1962).
Van Zwieten, P. A., The pharmacological properties of lipophilic calcium antagonists. Blood Pres., 2, 5–9 (1998).
Yamada, Y., Yokota, M., Furumichi, T., Furui, H., Yamauchi, K., and Saito, H., Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability. Cardiovasc Res., 24, 993–997 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halici, Z., Suleyman, H. & Cadirci, E. Effects of calcium channel blockers on hyaluronidase-induced capillary vascular permeability. Arch. Pharm. Res. 31, 891–899 (2008). https://doi.org/10.1007/s12272-001-1243-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-1243-0